Category: Clinical Trial
Clinical Trial market research reports by GlobalData
-
Esophageal Cancer Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Esophageal Cancer Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Esophageal Cancer therapeutics. Synopsis In 2022, there will be more than 440,000 diagnosed prev ... Read More
-
Axial Spondyloarthritis (axSpA) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Axial Spondyloarthritis (axSpA) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in axSpA therapeutics. Synopsis In 2022, there will be more than 10.7 million diagnos ... Read More
-
Asthma Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Asthma Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Asthma therapeutics. Synopsis In 2022, there will be more than 260.6 million diagnosed prevalent cases of A ... Read More
-
Clinical Trials - The Movement Towards Decentralized Clinical Trials
Clinical Trials - The Movement Towards Decentralized Clinical Trials Summary This report provides an analysis on DCT's/Virtual trials. Key Highlights DCT usage is on the rise North America has conducted the most DCTs Mobile Healthcare is the top virtual component used Scope The clinical trial data u ... Read More
-
Autoimmune Hepatitis Marketed and Pipeline Drugs Assessment, Clinical Trials, and Competitive Landscape
Autoimmune Hepatitis Marketed and Pipeline Drugs Assessment, Clinical Trials, and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Autoimmune Hepatitis therapeutics. Synopsis In 2022, there will be more than 36.000 diagnose ... Read More
-
Primary Biliary Cholangitis Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Primary Biliary Cholangitis Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Primary Biliary Cholangitis therapeutics. Synopsis In 2022, there will be more than 50 ... Read More
-
Phenylketonuria Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Phenylketonuria Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Phenylketonuria therapeutics. Synopsis In 2022, there will be more than 500,000 diagnosed prevalen ... Read More
-
Peripheral T-Cell Lymphomas (PTCL) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Peripheral T-Cell Lymphomas (PTCL) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update Summary GlobalData's clinical trial report, “Peripheral T-Cell Lymphomas (PTCL) Clinical Trial Analysis by Trial Phase, Trial Status ... Read More
-
Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update Summary GlobalData's clinical trial report, “Hormone Refractory (Castration Resistant, ... Read More
-
Systemic Sclerosis (Scleroderma) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Systemic Sclerosis (Scleroderma) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update Summary GlobalData's clinical trial report, “Systemic Sclerosis (Scleroderma) Clinical Trial Analysis by Trial Phase, Trial Status, Tr ... Read More
-
Polycystic Ovarian Syndrome Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Polycystic Ovarian Syndrome Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update Summary GlobalData's clinical trial report, “Polycystic Ovarian Syndrome Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts ... Read More
-
Hypertriglyceridemia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Hypertriglyceridemia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update Summary GlobalData's clinical trial report, “Hypertriglyceridemia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, ... Read More
-
Osteoarthritis Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021 - 2031
Osteoarthritis Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021 - 2031 Summary Osteoarthritis (OA) is the most common joint disease and a major cause of disability and pain among the elderly in ... Read More
-
Gingivitis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Gingivitis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update Summary GlobalData's clinical trial report, “Gingivitis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type ... Read More
-
Leishmaniasis (Kala-Azar) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Leishmaniasis (Kala-Azar) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update Summary GlobalData's clinical trial report, “Leishmaniasis (Kala-Azar) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, En ... Read More
-
Myasthenia Gravis Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Myasthenia Gravis Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Myasthenia Gravis therapeutics. Synopsis In 2022, there will be more than 700,000 prevalent case ... Read More
-
Gallbladder Cancer Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Gallbladder Cancer Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update Summary GlobalData's clinical trial report, “Gallbladder Cancer Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Stat ... Read More
-
Febrile Neutropenia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Febrile Neutropenia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update Summary GlobalData's clinical trial report, “Febrile Neutropenia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, St ... Read More
-
Egypt Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape
Egypt Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape Summary GlobalData, the industry analysis specialist, has released its latest report: “Egypt Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Compe ... Read More
-
Schizophrenia Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031
Schizophrenia Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031 Summary Schizophrenia is a heterogeneous behavioral and cognitive syndrome involving chronic or recurrent psychosis. The diso ... Read More
-
Greece Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape
Greece Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape Summary GlobalData, the industry analysis specialist, has released its latest report “Greece Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Comp ... Read More
-
HER2- Breast Cancer Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
HER2- Breast Cancer Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in HER2- Breast Cancer therapeutics. Synopsis In 2022, there will be more than one million incide ... Read More
-
Hospital Acquired Pneumonia Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Hospital Acquired Pneumonia Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Hospital Acquired Pneumonia therapeutics. Synopsis In 2022, there will be more than 30 ... Read More
-
Coronavirus Disease 2019 (COVID-19) Impact on Clinical Trials, 2022 Update
Coronavirus Disease 2019 (COVID-19) Impact on Clinical Trials, 2022 Update Summary This 55-page PowerPoint based report gives an important update to the previous year with an expert analysis on how COVID-19 is impacting clinical trials and the potential move toward decentralized clinical trials. Fin ... Read More
-
Urticaria Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Urticaria Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Urticaria therapeutics. Synopsis In 2022, there will be more than 80 million diagnosed prevalent cases o ... Read More
Research Assistance
